Penn Davis Mcfarland Inc Abbott Laboratories Transaction History
Penn Davis Mcfarland Inc
- $953 Million
- Q3 2025
A detailed history of Penn Davis Mcfarland Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Penn Davis Mcfarland Inc holds 31,275 shares of ABT stock, worth $3.98 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
31,275
Previous 31,275
-0.0%
Holding current value
$3.98 Million
Previous $4.25 Million
1.53%
% of portfolio
0.44%
Previous 0.49%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,608Shares Held
1.4BCall Options Held
9.22MPut Options Held
8.09M-
Vanguard Group Inc Valley Forge, PA173MShares$22 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$9.97 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.65 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.31 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $223B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...